Myda Advisors LLC Rocket Pharmaceuticals, Inc. Transaction History
Myda Advisors LLC
- $443 Million
- Q2 2025
A detailed history of Myda Advisors LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Myda Advisors LLC holds 21,200 shares of RCKT stock, worth $66,780. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,200
Previous 460,381
95.4%
Holding current value
$66,780
Previous $3.07 Million
98.34%
% of portfolio
0.01%
Previous 0.57%
Shares
2 transactions
Others Institutions Holding RCKT
# of Institutions
221Shares Held
98.4MCall Options Held
611KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$55.7 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$26.3 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$19.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$19.3 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$15.2 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $238M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...